SNH can promote the excessive accumulation of ROS in MCF-7 and CMT-1211 cells, target the PI3K-AKT-GSK3β pathway to induce cell apoptosis in vitro, and significantly inhibit the growth of breast tumors in vivo. The gene discussed is GSK3B; the disease is breast neoplasm.